ALK and retinal disorder: The therapeuticpotential of ALK-001 was demonstrated in a murine model ofABCA4-associated retinopathy, by showing a reduced A2Edimer formation and lipofuscin accumulation compared to age-matchedwild-type mice (Charbel Issa et al.,2015).